GENEVA, Aug. 4 -- APGEN THERAPEUTICS AB (Jordgrand 5419274 Sollentuna) filed a patent application (PCT/EP2025/051806) for "IMMUNOTHERAPY FOR THE TREATMENT OF CANCER" on Jan 24, 2025. With publication no. WO/2025/157999, the details related to the patent application was published on Jul 31, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MELIEF, Jeroen (Kleverparkweg 642023 CH Haarlem)
Abstract:
The invention relates to improved immunogenicity of tumor cells by treating them ex vivo or directly in vivo with a combination of (i) a BET inhibitor and (ii) an RIG-I-like receptor agonist (RLR a...